CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
CN Stock MarketDetailed Quotes
600315 Shanghai Jahwa United
- 23.42
- -0.63-2.62%
Market Closed Apr 30 15:00 CST
15.74BMarket Cap-18.06P/E (TTM)
24.30High23.34Low100.80KlotVolume23.88Open24.05Pre Close239.97MTurnover1.50%Turnover RatioLossP/E (Static)672.23MShares24.3052wk High2.30P/B15.74BFloat Cap13.6452wk Low26.46Limit Up672.23MShs Float62.91Historical High21.65Limit Down3.99%Amplitude-3.97Historical Low0.26Dividend TTM23.81Avg Price54.39KlotAsk1.11%Div YieldTTM100Lot Size38.83KlotBid
Shanghai Jahwa United Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -10.59%1.7B | -13.93%5.68B | -12.07%4.48B | -8.51%3.32B | -3.76%1.91B | -7.16%6.6B | -4.91%5.09B | -2.30%3.63B | -6.49%1.98B | -7.06%7.11B |
| Operating revenue | -10.59%1.7B | -13.93%5.68B | -12.07%4.48B | -8.51%3.32B | -3.76%1.91B | -7.16%6.6B | -4.91%5.09B | -2.30%3.63B | -6.49%1.98B | -7.06%7.11B |
| Other operating revenue | ---- | -63.05%3.89M | ---- | -21.02%5.86M | ---- | 48.64%10.52M | ---- | 155.95%7.41M | ---- | -14.18%7.08M |
| Total operating cost | -5.78%1.5B | -6.31%5.89B | -10.33%4.39B | -9.60%3.09B | -10.53%1.6B | -3.60%6.29B | -2.14%4.89B | -2.34%3.42B | -5.46%1.78B | -8.45%6.53B |
| Operating cost | -10.92%623.46M | -11.05%2.41B | -11.84%1.82B | -10.54%1.29B | -8.88%699.9M | -11.17%2.71B | -7.95%2.06B | -3.11%1.44B | -2.84%768.12M | -3.42%3.05B |
| Operating tax surcharges | -21.96%11.1M | -7.13%42.66M | -0.92%31.76M | 6.81%23.74M | 27.67%14.22M | -4.69%45.93M | 3.78%32.05M | -7.02%22.23M | -9.37%11.14M | -18.46%48.2M |
| Operating expense | -2.89%688.47M | -4.28%2.65B | -8.66%2.02B | -8.74%1.44B | -11.97%708.94M | 4.44%2.77B | 4.15%2.21B | -1.69%1.58B | -4.35%805.35M | -9.98%2.65B |
| Administration expense | 8.12%134.02M | -1.07%609.7M | -18.03%382.91M | -17.12%251.12M | -31.37%123.96M | -1.91%616.27M | -8.38%467.17M | -5.09%303M | -12.31%180.61M | -20.56%628.3M |
| Financial expense | -46.31%7.19M | 558.40%30.77M | 343.14%31.73M | 856.04%18.27M | 190.10%13.38M | 143.91%4.67M | 180.94%7.16M | -4,648.45%-2.42M | -520.44%-14.85M | -185.03%-10.64M |
| -Interest expense (Financial expense) | -25.13%11.53M | -4.22%65.06M | -0.16%50.99M | -1.73%29.31M | 3.44%15.4M | 50.12%67.93M | 64.43%51.07M | 50.98%29.83M | 59.30%14.89M | 54.59%45.25M |
| -Interest Income (Financial expense) | 8.93%-8.25M | 9.87%-40.36M | 7.60%-30.37M | 6.96%-20.55M | 3.41%-9.06M | -30.22%-44.78M | -32.07%-32.87M | -38.35%-22.09M | -42.55%-9.38M | -34.86%-34.39M |
| Research and development | 11.12%38.74M | 3.14%151.12M | -8.75%104.19M | -11.44%68.66M | 6.52%34.86M | -8.36%146.52M | 8.19%114.19M | 18.39%77.53M | 3.39%32.73M | -1.98%159.89M |
| Credit Impairment Loss | 215.01%5.35M | 160.70%17.56M | 517.40%13.91M | 78.88%-2.54M | 69.07%-4.65M | -59.89%-28.92M | -214.16%-3.33M | -10.24%-12.02M | -4.04%-15.03M | -188.96%-18.09M |
| Asset Impairment Loss | -189.01%-11.84M | -1,637.81%-609.5M | 225.11%21.86M | 249.09%7.96M | -2,616.28%-4.1M | -20.69%-35.07M | 21.56%-17.47M | 69.28%-5.34M | 101.20%162.76K | 26.88%-29.06M |
| Other net revenue | 184.70%31.89M | -359.09%-644.87M | -72.89%66.22M | -96.41%5M | -166.56%-37.65M | 769.22%248.9M | 1,115.88%244.22M | 2,535.96%139.52M | 1,427.66%56.58M | -115.90%-37.19M |
| Fair value change income | 115.81%9.02M | -175.54%-84.18M | -120.64%-19.59M | -174.01%-50.66M | -313.52%-57.05M | 208.09%111.44M | 275.23%94.95M | 297.56%68.45M | 327.93%26.72M | -146.47%-103.1M |
| Invest income | -14.84%13.34M | -159.55%-50.87M | -86.22%14.68M | -56.51%25.39M | -48.71%15.67M | 99.85%85.43M | 151.04%106.54M | 114.71%58.37M | -1.72%30.55M | -79.51%42.75M |
| -Including: Investment income associates | -50.83%3.56M | -1,021.88%-107.07M | -260.62%-30.68M | -120.00%-5.5M | -69.82%7.24M | 65.95%-9.54M | 524.45%19.1M | 1,155.78%27.53M | 53.04%24.01M | -126.36%-28.03M |
| Asset deal income | 425.67%4.22M | 2,149.74%276.92K | 3,625.53%823.76K | 2,519.63%831.24K | 4,095.62%802.7K | -98.86%12.31K | -102.28%-23.37K | -107.55%-34.35K | 129.20%19.13K | 170.22%1.08M |
| Other revenue | 1.10%11.8M | -29.45%81.84M | -45.66%34.54M | -20.18%24.02M | -17.58%11.67M | 67.59%116.02M | 26.72%63.57M | 1.81%30.1M | 13.48%14.16M | -21.42%69.23M |
| Operating profit | -14.66%232.53M | -254.65%-860.02M | -64.90%155.51M | -33.09%231.57M | 7.61%272.49M | 2.32%556.12M | 18.21%443M | 69.41%346.11M | 7.83%253.23M | -27.75%543.51M |
| Add:Non operating Income | 104.46%5.85M | 154.86%33.15M | 212.40%24.23M | 342.14%21.23M | 97.18%2.86M | 82.71%13.01M | 91.00%7.76M | 158.00%4.8M | 5.68%1.45M | -50.43%7.12M |
| Less:Non operating expense | 230.04%512.33K | -47.43%2.98M | -88.12%528.89K | -91.18%349.88K | -96.05%155.23K | 224.76%5.67M | 3,054.39%4.45M | 1,437.18%3.97M | 351.75%3.93M | -24.52%1.75M |
| Total profit | -13.56%237.87M | -247.28%-829.85M | -59.84%179.22M | -27.24%252.46M | 9.75%275.19M | 2.66%563.46M | 17.77%446.3M | 68.04%346.95M | 6.55%250.75M | -28.19%548.88M |
| Less:Income tax cost | 9.21%20.73M | -94.89%3.24M | -68.35%16.51M | -68.55%14.45M | -6.51%18.98M | -17.48%63.41M | -20.66%52.17M | -5.82%45.95M | -43.56%20.31M | -33.23%76.84M |
| Net profit | -15.25%217.13M | -266.60%-833.09M | -58.72%162.7M | -20.93%238M | 11.18%256.21M | 5.93%500.05M | 25.83%394.13M | 90.90%301M | 15.59%230.44M | -27.29%472.04M |
| Net profit from continuing operation | -15.25%217.13M | -266.60%-833.09M | -58.72%162.7M | -20.93%238M | 11.18%256.21M | 5.93%500.05M | 25.83%394.13M | 90.90%301M | --230.44M | -27.29%472.04M |
| Net profit of parent company owners | -15.25%217.13M | -266.60%-833.09M | -58.72%162.7M | -20.93%238M | 11.18%256.21M | 5.93%500.05M | 25.83%394.13M | 90.90%301M | 15.59%230.44M | -27.29%472.04M |
| Earning per share | ||||||||||
| Basic earning per share | -15.79%0.32 | -265.33%-1.24 | -59.32%0.24 | -22.22%0.35 | 11.76%0.38 | 7.14%0.75 | 25.53%0.59 | 95.65%0.45 | 13.33%0.34 | -27.84%0.7 |
| Diluted earning per share | -15.79%0.32 | -265.33%-1.24 | -59.32%0.24 | -22.22%0.35 | 11.76%0.38 | 7.14%0.75 | 25.53%0.59 | 95.65%0.45 | 13.33%0.34 | -27.08%0.7 |
| Other composite income | 253.05%39.11M | -91.74%9.5M | -1.43%60.36M | -110.04%-16.37M | -1,044.87%-25.55M | 414.66%115.09M | 162.93%61.23M | 276.01%163M | 104.62%2.7M | 44.78%-36.58M |
| Other composite income of parent company owners | 253.05%39.11M | -91.74%9.5M | -1.43%60.36M | -110.04%-16.37M | -1,044.87%-25.55M | 414.66%115.09M | 162.93%61.23M | 276.01%163M | 104.62%2.7M | 44.78%-36.58M |
| Total composite income | 11.10%256.25M | -233.89%-823.59M | -51.01%223.06M | -52.23%221.63M | -1.07%230.65M | 41.26%615.14M | 110.89%455.36M | 613.15%464M | 65.56%233.15M | -25.31%435.46M |
| Total composite income of parent company owners | 11.10%256.25M | -233.89%-823.59M | -51.01%223.06M | -52.23%221.63M | -1.07%230.65M | 41.26%615.14M | 110.89%455.36M | 613.15%464M | 65.56%233.15M | -25.31%435.46M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.